We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Nestle Partners With French Firm To Develop Infant Milk Allergy Test

May 31, 2016: 12:00 AM EST
Nestlé Health Science is partnering with French company DBV Technologies to develop and market a patch-test tool to diagnose cow’s milk protein allergy (CMPA) in infants, a difficult-to diagnose condition that affects as many as three percent of babies. Symptoms of the condition – eczema, reflux, constipation, diarrhea, crying, etc. – often mask CMPA. The new DBV diagnostic tool will be based on its Viaskin technology and will be designed to be ready-to-use and standardized. As a result of the partnership, Nestlé Health Science will have the exclusive worldwide commercialization rights for the tool.
"Nestlé Health Science collaborates with DBV Technologies to accelerate development of an innovative diagnostic tool for Cow’s Milk Protein Allergy", News release, Nestlé, May 31, 2016, © Nestlé
Companies, Organizations
Deals, M&A, JVs, Licensing
Innovation & New Ideas
Press Release
Developed by Yuri Ingultsov Software Lab.